Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT2080221848Phase 1
Phase 1, randomised, double-blind trial of Z-100 (5 arms), sponsored by Zeria Pharmaceutical Co., Ltd. Primary endpoint: Immunological parameters.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT2080221848.